These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36294202)

  • 1. Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium(III)-Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells.
    Noureldeen AFH; Aziz SW; Shouman SA; Mohamed MM; Attia YM; Ramadan RM; Elhady MM
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents.
    Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS
    Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel hybrids targeting mTOR and HDACs for potential treatment of hepatocellular carcinoma.
    Zhai S; Zhang H; Chen R; Wu J; Ai D; Tao S; Cai Y; Zhang JQ; Wang L
    Eur J Med Chem; 2021 Dec; 225():113824. PubMed ID: 34509167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactive platinum complex of ligand bearing pyrimidine skeleton: DNA/BSA binding, molecular docking, anticancer, antioxidant and antimicrobial activities.
    Sankarganesh M; Adwin Jose PR; Dhaveethu Raja J; Vijay Solomon R; Dorothy Sheela C; Gurusamy S
    J Biomol Struct Dyn; 2022 Sep; 40(15):6683-6696. PubMed ID: 33634734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
    Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
    Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structural characterization, and biological studies of ATBS-M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents.
    Ismael M; Abdel-Rahman LH; Abou El-Ezz D; Ahmed EA; Nafady A
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000241. PubMed ID: 33336849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectroscopic, Computational, Antimicrobial, DNA Interaction, In Vitro Anticancer and Molecular Docking Properties of Biochemically Active Cu(II) and Zn(II) Complexes of Pyrimidine-Ligand.
    Sankarganesh M; Dhaveethu Raja J; Adwin Jose PR; Vinoth Kumar GG; Rajesh J; Rajasekaran R
    J Fluoresc; 2018 Jul; 28(4):975-985. PubMed ID: 29961205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway.
    Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, spectral characterization, thermal, DFT studies and anticancer cell line activities of Co(II), Ni(II) and Cu(II) complexes of Schiff bases derived from 4-amino-5-(pyridin-4-yl)-4H-1,2,4-triazole-3-thiol.
    Tyagi P; Chandra S; Saraswat BS; Yadav D
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jun; 145():155-164. PubMed ID: 25770965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway.
    Noser AA; Abdelmonsef AH; El-Naggar M; Salem MM
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New tailored substituted benzothiazole Schiff base Cu(II)/Zn(II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic activity.
    Zehra S; Shavez Khan M; Ahmad I; Arjmand F
    J Biomol Struct Dyn; 2019 Apr; 37(7):1863-1879. PubMed ID: 29676660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A coordinated ruthenium-rifampicin complex reprogramming the colon carcinoma micro-environment mediated by modulation of p53/AkT/mTOR/VEGF pathway.
    Zeng J; Zhao Y; Li K; Long D; Li W; Liang L
    Toxicol Appl Pharmacol; 2021 Sep; 426():115618. PubMed ID: 34126112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apple polyphenol phloretin complexed with ruthenium is capable of reprogramming the breast cancer microenvironment through modulation of PI3K/Akt/mTOR/VEGF pathways.
    Roy S; Mondru AK; Chakraborty T; Das A; Dasgupta S
    Toxicol Appl Pharmacol; 2022 Jan; 434():115822. PubMed ID: 34896434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
    Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A newly synthesized thiosemicarbazide derivative trigger apoptosis rather than necroptosis on HEPG2 cell line.
    Başoğlu-Ünal F; Becer E; Ensarioğlu HK; -Güzeldemirci NU; Kuran ED; Vatansever HS
    Chem Biol Drug Des; 2024 Jan; 103(1):e14355. PubMed ID: 37776268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC195 induces apoptosis and endoplastic reticulum stress in human hepatocellular carcinoma cells by inhibiting the PI3K/Akt/mTOR signaling pathway.
    Chen XL; Fu JP; Shi J; Wan P; Cao H; Tang ZM
    Mol Med Rep; 2015 Dec; 12(6):8229-36. PubMed ID: 26496900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.